Celgene and GlobeImmune form a Cancer Partnership
By Taskin Ahmed
Pharma Deals Review: Vol 2009 Issue 6 (Table of Contents)
Published: 11 Jun-2009
DOI: 10.3833/pdr.v2009.i6.1118 ISSN: 1756-7874
Section: Licensing
Fulltext:
Abstract
GlobeImmune and Celgene Corporation agreed on a strategic alliance that will develop drugs that stimulate the immune system against cancer using GlobeImmune’s Tarmogen® technology...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018